99 related articles for article (PubMed ID: 30905461)
41. Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults.
Zulet MA; Puchau B; Hermsdorff HH; Navarro C; Martínez JA
Nutr Res; 2009 Jan; 29(1):41-8. PubMed ID: 19185776
[TBL] [Abstract][Full Text] [Related]
42. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma.
Kongtawelert P; Tangkijvanich P; Ong-Chai S; Poovorawan Y
World J Gastroenterol; 2003 Oct; 9(10):2178-81. PubMed ID: 14562373
[TBL] [Abstract][Full Text] [Related]
43. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
Allegretti AS; Ortiz G; Kalim S; Wibecan J; Zhang D; Shan HY; Xu D; Chung RT; Karumanchi SA; Thadhani RI
Dig Dis Sci; 2016 Dec; 61(12):3609-3620. PubMed ID: 27655105
[TBL] [Abstract][Full Text] [Related]
44. Sialic acid and anti-ganglioside antibody levels in children with autism spectrum disorders.
Yang X; Liang S; Wang L; Han P; Jiang X; Wang J; Hao Y; Wu L
Brain Res; 2018 Jan; 1678():273-277. PubMed ID: 29102779
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
46. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
47. The concentration of total sialic acid in chronic hepatitis B and C.
Gruszewska E; Cylwik B; Gudowska M; Panasiuk A; Flisiak R; Chrostek L
Ann Clin Biochem; 2019 Jan; 56(1):118-122. PubMed ID: 30027776
[TBL] [Abstract][Full Text] [Related]
48. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
[TBL] [Abstract][Full Text] [Related]
49. Sialic acid levels in the blood in pregnant women with impaired glucose tolerance test.
Findik RB; Yilmaz FM; Yilmaz G; Yilmaz H; Karakaya J
Arch Gynecol Obstet; 2012 Oct; 286(4):913-6. PubMed ID: 22695824
[TBL] [Abstract][Full Text] [Related]
50. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
51. Serum total sialic acid as a novel complementary candidate marker of hepatic damage in obstructive jaundice.
Alturfan AA; Aytaç E; Emekli-Alturfan E; Yarat A; Sarıbeyoğlu K; Pekmezci S; Seymen O
Ann Clin Lab Sci; 2014; 44(1):56-61. PubMed ID: 24695475
[TBL] [Abstract][Full Text] [Related]
52. Serum sialic acid as a marker of pancreatic cancers.
Gruszewska E; Chrostek L; Cylwik B; Tobolczyk J; Szmitkowski M; Kuklinski A; Kedra B
Clin Lab; 2013; 59(7-8):781-8. PubMed ID: 24133906
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
[TBL] [Abstract][Full Text] [Related]
54. Serum level of sialic acid (SA) and carbohydrate-deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications.
Cylwik B; Chrostek L; Jakimiuk B; Popławska A; Szmitkowski M
J Clin Lab Anal; 2006; 20(2):68-73. PubMed ID: 16538641
[TBL] [Abstract][Full Text] [Related]
55. Levels of serum sialic acid and thiobarbituric acid reactive substances in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
Yilmaz G; Yilmaz FM; Aral Y; Yucel D
J Clin Lab Anal; 2007; 21(5):260-4. PubMed ID: 17847112
[TBL] [Abstract][Full Text] [Related]
56. Cytidine-5'-monophosphate-N-acetylneuraminic acid. Asialoglycoprotein sialic acid transferase activity in liver and serum of patients with juvenile hepatic cirrhosis and alpha-1-antitrypsin deficiency.
Kuhlenschmidt MS; Peters SP; Pinkard OD; Glew RH; Sharp H
Biochim Biophys Acta; 1976 Apr; 429(2):359-73. PubMed ID: 1083250
[TBL] [Abstract][Full Text] [Related]
57. Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women.
Browning LM; Jebb SA; Mishra GD; Cooke JH; O'Connell MA; Crook MA; Krebs JD
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1004-10. PubMed ID: 15211367
[TBL] [Abstract][Full Text] [Related]
58. Low-glycosylated forms of both FSH and LH play major roles in the natural ovarian stimulation.
Wide L; Eriksson K
Ups J Med Sci; 2018 Jun; 123(2):100-108. PubMed ID: 29894213
[TBL] [Abstract][Full Text] [Related]
59. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
60. Occurrence of sialic acids in healthy humans and different disorders.
Sillanaukee P; Pönniö M; Jääskeläinen IP
Eur J Clin Invest; 1999 May; 29(5):413-25. PubMed ID: 10354198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
